May 1, 2024 - April 30, 2026

One of the premier peer-reviewed clinical journals in general and internal medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications...

Email CNE@mayo.edu if you are interested in package purchase pricing, or if your organization is interested in purchasing for departmental use.

Available until February 1, 2026

Nearly 1 million individuals in the U.S. have multiple sclerosis. Most acquire the disease between the ages of 20 and 50. It’s often difficult to establish a diagnosis as the symptoms can be vague and often vary significantly from one individual to another. The disease can be very frightening, often debilitating, and progressive; up until recently, we’ve had very little to offer patients in the way of treatment. However, in the past few years there have been numerous advances in treatment options which have given hope to the many patients with MS. We’ll be discussing multiple sclerosis in this podcast. Our guest is Eoin Flanagan, M.B., B.Ch., a neurologist from the Department of Neurology at the Mayo Clinic.

Available until September 2024- Online CME Course

Available until September 1, 2024 - Podcast Online CME Education

Benjamin J. Anderson, PharmD, MPH, FASHP and Diana J. Schreier, PharmD, MBA, BCPS recognize the history and regulations for prospective medication order review, describe the technical landscape for verification decision support and explore real-world verification decision support outcomes.

Available until February 1, 2026

Summary: Flu and cold season is an annual concern for people around the world. Specifically in the United States, there are massive disparities in both care and outcomes for communities of color related to both diagnosis and treatment of flu and cold. On this episode of the RISE for Equity podcast, Dr. Nusheen Ameenuddin joins host Nicole Nfonoyim-Hara to discuss COVID’s impact on cold and flu, protecting our communities, and how we can improve education and access to care for marginalized communities. “The truth of the matter is genetically, we're all very similar. It's not an issue of race, it's an issue of racism. When we actually step back, people can be like, ‘Oh, that situation was a one-off.’ And when we actually look at the data, it's not a one-off. The fact is, we're not asking the right questions, and we need to look deeper to ensure that we are providing the best possible care, the most objective care, the most patient-centered care, particularly when we see that we're falling short. And, and the numbers don't lie.” - Dr. Nusheen Ameenuddin Guest: Dr. Nusheen Ameenuddin is currently an Assistant Professor and Consultant (tenured staff physician) in the Division of Community Pediatric and Adolescent Medicine, Department of Pediatrics, at the Mayo Clinic, Rochester, MN. Please visit the RISE for Equity website for more information.

Available until February 1, 2026

The liver is the second most commonly transplanted organ; nearly 10,000 patients received a liver transplant in 2021. The major factor, which has limited the transplants performed, has been the availability of the donated organs and some patients have waited several years before an acceptable organ becomes available. Transplants can be performed for a variety of end-stage liver diseases, usually giving patients years of additional life. Who’s a candidate for a liver transplant and what criteria for selection are required? Our topic for this podcast is “Liver Transplant Selection Criteria” and we’ll discuss this topic with our guest, Michael D. Leise, M.D., from the Division of Gastroenterology and Hepatology at the Mayo Clinic.